Abstract
The clinical efficacy of primary angioplasty for acute myocardial infarction (AMI) is limited by recurrent myocardial ischemia during the hospital stay and restenosis in the months thereafter. 1 With the application of more effective poststenting antithrombotic regimens 2 and the improvement in stent implantation techniques, 3 coronary stenting is no longer considered contraindicated in thrombus-containing lesions and has gained substantial popularity in the setting of AMI. Recently, several randomized clinical trials have been conducted that compared coronary stenting and balloon angioplasty as the primary revascularization strategy for AMI. 4 ‐14 In the present study, we performed a meta-analysis of all the reported randomized trials to assess the overall comparative efficacy of these 2 strategies on major clinical outcomes in AMI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
